A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma

References

• Bray F , Ferlay J , Soerjomataram I , Siegel RL , Torre LA , Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2018;68(6):394–424. doi:10.3322/caac.21492 30207593
   PubMed Web of Science ®Google Scholar
• Yang JD , Hainaut P , Gores GJ , Amadou A , Plymoth A , Roberts LR . A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol . 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y 31439937
   PubMed Web of Science ®Google Scholar
• Vibert E , Schwartz M , Olthoff KM . Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol . 2020;72(2):262–276. doi:10.1016/j.jhep.2019.11.017 31954491
   PubMed Web of Science ®Google Scholar
• Chen LJ , Chang YJ , Chang YJ . Survival predictability between the American joint committee on cancer, eighth edition staging system and the barcelona clinic liver cancer classification in patients with hepatocellular carcinoma. Oncologist . 2020. doi:10.1002/onco.13535
   Web of Science ®Google Scholar
• Tsilimigras DI , Bagante F , Sahara K , et al. Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol . 2019;26(11):3693–3700. doi:10.1245/s10434-019-07580-9 31267302
   PubMed Web of Science ®Google Scholar
• Lin CY , Kee KM , Wang JH , et al. Is the cancer of the liver italian program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups. Liver Int . 2009;29:74–81. doi:10.1111/j.1478-3231.2008.01702.x
   PubMed Web of Science ®Google Scholar
• Lu W , Dong J , Huang Z , Guo D , Liu Y , Shi S . Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol . 2008;23(12):1874–1878. doi:10.1111/j.1440-1746.2008.05527.x 18752560
   PubMed Web of Science ®Google Scholar
• Marasco G , Colecchia A , Colli A , et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. J Hepatol . 2019;70(3):440–448. doi:10.1016/j.jhep.2018.10.022 30389551
   PubMed Web of Science ®Google Scholar
• Schütte K , Tippelt B , Schulz C , et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr . 2015;34(6):1122–1127. doi:10.1016/j.clnu.2014.11.007 25434576
   PubMed Web of Science ®Google Scholar
• Hu B , Yang X-R , Xu Y , et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res . 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442 25271081
   PubMed Web of Science ®Google Scholar
• Huitzil-Melendez F-D , Capanu M , O’Reilly EM , et al. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol . 2010;28(17):2889–2895. doi:10.1200/JCO.2009.25.9895 20458042
   PubMed Web of Science ®Google Scholar
• Addissie BD , Roberts LR . Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making. Clin Liver Dis . 2015;19(2):277–294. doi:10.1016/j.cld.2015.01.011 25921663
   PubMed Web of Science ®Google Scholar
• Parikh ND , Singal AG . The ITA.LI.CA staging system: a novel staging system for hepatocellular carcinoma. PLOS Med . 2016;13(4):e1002005. doi:10.1371/journal.pmed.1002005 27116028
   PubMed Web of Science ®Google Scholar
• Yau T , Tang VY , Yao TJ , Fan ST , Lo CM , Poon RT . Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology . 2014;146:1691–700.e3. doi:10.1053/j.gastro.2014.02.032 24583061
   PubMed Web of Science ®Google Scholar
• Iasonos A , Schrag D , Raj GV , Panageas KS . How to build and interpret a nomogram for cancer prognosis. J Clin Oncol . 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791 18323559
   PubMed Web of Science ®Google Scholar
• Balachandran VP , Gonen M , Smith JJ , DeMatteo RP . Nomograms in oncology: more than meets the eye. Lancet Oncol . 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-7 25846097
   PubMed Web of Science ®Google Scholar
• Huang DD , Huang SL , Zhuang CL , et al. Sarcopenia, as defined by low muscle mass, strength, and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis . 2015;17(11):O256–O264. doi:10.1111/codi.13067 26194849
   PubMed Web of Science ®Google Scholar
• Wang S-L , Zhuang C-L , Huang -D-D . Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a Prospective Study. Ann Surg Oncol . 2016;23(2):556–564. doi:10.1245/s10434-015-4887-3 26668085
   PubMed Web of Science ®Google Scholar
• Prado CMM , Lieffers JR , Mccargar LJ , et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol . 2008;9(7):605–607. doi:10.1016/S1470-2045(08)70153-0 18598925
   PubMed Web of Science ®Google Scholar
• Malietzis G , Currie AC , Athanasiou T , et al. Influence of body composition profile on outcomes following colorectal cancer surgery[J]. Br J Surg . 2016;103(5):572–580. doi:10.1002/bjs.10075 26994716
   PubMed Web of Science ®Google Scholar
• Pecorelli N , Carrara G , Cobelli FD , et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg . 2016;103(4):434–442. doi:10.1002/bjs.10063 26780231
   PubMed Web of Science ®Google Scholar
• Van Den Berg HA . Occam’s razor: from ockham’s via moderna to modern data science. Sci Prog . 2018;101:261–272. doi:10.3184/003685018X15295002645082 30025552
   PubMed Web of Science ®Google Scholar
• Weiser MR , Landmann RG , Kattan MW , et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol . 2008;26(3):380–385. doi:10.1200/JCO.2007.14.1291 18202413
   PubMed Web of Science ®Google Scholar
• Xu L , Peng ZW , Chen MS , et al. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. J Hepatol . 2015;63:122–130. doi:10.1016/j.jhep.2015.02.034 25725438
   PubMed Web of Science ®Google Scholar
• Huang Y-Q , Liang C-H , He L , et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol . 2016;34(18):2157–2164. doi:10.1200/JCO.2015.65.9128 27138577
   PubMed Web of Science ®Google Scholar
• Rousson V , Zumbrunn T . Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inform Decis Mak . 2011;11(1):45. doi:10.1186/1472-6947-11-45 21696604
   PubMed Web of Science ®Google Scholar
• Kerr KF , Brown MD , Zhu K , Janes H . Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol . 2016;34(21):2534–2540. doi:10.1200/JCO.2015.65.5654 27247223
   PubMed Web of Science ®Google Scholar
• Lamain-de Ruiter M , Kwee A , Naaktgeboren CA , et al. External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. BMJ . 2016;354:i4338. doi:10.1136/bmj.i4338 27576867
   PubMed Web of Science ®Google Scholar
• Liao R , Peng C , Li M , et al. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy. Cancer Med . 2018;7(4):1170–1182. doi:10.1002/cam4.1424 29533004
   PubMed Web of Science ®Google Scholar
• Chen L , Cai BB , Zhou CJ , et al. A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma. Cancer Manag Res . 2019;11:693–703. doi:10.2147/CMAR.S193593 30679923
   PubMed Web of Science ®Google Scholar
• Du M , Zhang S , Xiao L , et al. The relationship between serum bilirubin and elevated fibrotic indices among HBV carriers: a cross-sectional study of a Chinese population. Int J Mol Sci . 2016;17(12):2057. doi:10.3390/ijms17122057
   PubMed Web of Science ®Google Scholar
• Carr BI , Guerra V , Giannini EG , et al. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype. Semin Oncol . 2014;41(2):252–258. doi:10.1053/j.seminoncol.2014.03.006 24787296
   PubMed Web of Science ®Google Scholar
• Dai C-Y , Lin C-Y , Tsai P-C , et al. Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection. J Chin Med Assoc . 2018;81(2):155–163. doi:10.1016/j.jcma.2017.06.018 29217359
   PubMed Web of Science ®Google Scholar
• Fujiwara N , Nakagawa H , Kudo Y , et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol . 2015;63(1):131–140. doi:10.1016/j.jhep.2015.02.031 25724366
   PubMed Web of Science ®Google Scholar
• Hamaguchi Y , Kaido T , Okumura S , et al. Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci . 2015;22:475–485. doi:10.1002/jhbp.236 25755128
   PubMed Web of Science ®Google Scholar
• Voron T , Tselikas L , Pietrasz D , et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg . 2015;261(6):1173–1183. doi:10.1097/SLA.0000000000000743 24950264
   PubMed Web of Science ®Google Scholar
• Kobayashi A , Kaido T , Hamaguchi Y , et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg . 2019;269(5):924–931. doi:10.1097/SLA.0000000000002555 29064889
   PubMed Web of Science ®Google Scholar
• Zhang G , Li X , Sui C , et al. Incidence and risk factor analysis for sarcopenia in patients with cancer. Oncol Lett . 2016;11(2):1230–1234. doi:10.3892/ol.2015.4019 26893724
   PubMed Web of Science ®Google Scholar
• Shen S-L , Fu S-J , Chen B , et al. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection. Ann Surg Oncol . 2014;21(12):3802–3809. doi:10.1245/s10434-014-3771-x 24849520
   PubMed Web of Science ®Google Scholar
• Wang X-P , Mao MJ , He Z-L , et al. A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with hepatocellular carcinoma. J Cancer . 2017;8(11):2079–2087. doi:10.7150/jca.19181 28819409
   PubMed Web of Science ®Google Scholar
• Kato Y , Okamura Y , Sugiura T , et al. The impact of serosal invasion on prognosis after curative hepatectomy for hepatocellular carcinoma: invasion to adjacent organs and rupture of tumor were crucial tumor-related prognostic factors needed for survival. Dig Surg . 2018;35:155–163. doi:10.1159/000477270 28787731
   PubMed Web of Science ®Google Scholar
• Mähringer-Kunz A , Steinle V , Düber C , et al. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: the more, the worse? Liver Int . 2019;39(2):324–331. doi:10.1111/liv.13988 30318826
   PubMed Web of Science ®Google Scholar
• Mao M , Wang X , Song Y , et al. Novel prognostic scores based on plasma prothrombin time and fibrinogen levels in patients with AFP-negative hepatocellular carcinoma. Cancer Control . 2020;27(1):107327482091552. doi:10.1177/1073274820915520
   Web of Science ®Google Scholar